167 results
8-K
EX-99.1
DRRX
Durect Corp
30 Apr 24
Other Events
2:30pm
) is also being explored. In addition, POSIMIR® (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the innovative SABER®
8-K
EX-99.1
DRRX
Durect Corp
27 Mar 24
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:15pm
, POSIMIR® (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the innovative SABER®platform technology, is FDA-approved
8-K
EX-99.1
DRRX
Durect Corp
4 Mar 24
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada
11:37am
a Fast Track Designation. In addition, POSIMIR® (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the innovative SABER®
8-K
EX-99.1
7mq4r 7qs
13 Nov 23
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
4:15pm
8-K
EX-99.1
h3e alqy3rehv9w
7 Nov 23
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial
4:10pm
8-K
EX-99.1
p6kiruktekjjd44ospj
7 Sep 23
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial
9:02am
8-K
EX-99.1
xcoaatke
9 Aug 23
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
4:23pm
8-K
EX-99.1
jbkbo1oawfs
21 Jul 23
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
424B5
7ly52p7xor9
21 Jul 23
Prospectus supplement for primary offering
10:38am
8-K
EX-99.1
ik5v2mmphx 56kxhb
16 May 23
Regulation FD Disclosure
12:08pm
8-K
EX-99.1
tp2ocjvqjkguglgfx 9t
8 May 23
DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update
4:15pm
8-K
EX-99.1
oodn53p272b0 ak4
10 Apr 23
Company on track to report data from ongoing Phase 2b AHFIRM trial in 2H 2023
9:30am
8-K
EX-99.1
g397wdmdqr fe
28 Nov 22
DURECT Announces 1-for-10 Reverse Stock Split
7:31pm
8-K
EX-99.1
ftnk7p
2 Nov 22
DURECT Corporation Reports Third Quarter 2022 Financial Results and Update of Programs
4:16pm
8-K
EX-99.1
6nx90
6 Oct 22
Other Events
9:01am